
无数据
无数据
无数据
| CAS Number | 58-63-9 |
| Catalog Number | AG003510(AGN-PC-0OCRFW) |
| Chemical Name | 9-β-D-Ribofuranosylhypoxanthine |
| EC Number | 200-390-4 |
| IUPAC Name | 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one |
| InChI | InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1 |
| InChI Key | UGQMRVRMYYASKQ-KQYNXXCUSA-N |
| MDL Number | MFCD00066770 |
| Molecular Formula | C10H12N4O5 |
| Molecular Weight | 268.2261 |
| SMILES | O[C@H]1[C@@H](O[C@@H]([C@H]1O)CO)N1C=2NC=NC(C2N=C1)=O |
| UNII | 5A614L51CT |
| Synonyms | Inosine,
inosine,
58-63-9,
Hypoxanthosine,
Ribonosine,
Atorel,
Oxiamin,
Trophicardyl,
Selfer,
Pantholic-L,
Panholic-L,
Hypoxanthine riboside,
Hypoxanthine ribonucleoside,
beta-Inosine,
Hypoxanthine D-riboside,
(-)-Inosine,
Hypoxanthine nucleoside,
Inosinum,
Inosina,
9-beta-D-Ribofuranosylhypoxanthine,
INO 495,
Inosie,
iso-prinosine,
Inosine [INN:JAN],
Inosinum [INN-Latin],
Inosina [INN-Spanish],
hypoxanthine-ribose,
Hypoxanthine-9-beta-D-ribofuranoside,
NSC 20262,
Hypoxanthine, 9-beta-D-ribofuranosyl-,
Inosin,
AI3-52241,
MFCD00066770,
beta-D-Ribofuranoside, hypoxanthine-9,
UNII-5A614L51CT,
HXR,
EINECS 200-390-4,
Hypoxanthine 9-beta-D-ribofuranoside,
MLS000028518,
CHEBI:17596,
UGQMRVRMYYASKQ-KQYNXXCUSA-N,
5A614L51CT,
9.beta.-D-Ribofuranosylhypoxanthine,
INO,
Inosine, 99%,
SMR000058316,
DSSTox_CID_25993,
DSSTox_RID_81278,
DSSTox_GSID_45993,
1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one,
.beta.-Inosine,
(2R,3R,4S,5R)-2-(6-Hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one,
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one,
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one,
CAS-58-63-9,
NOS,
SR-01000721862,
Hypoxanthine-9-D-ribofuranoside,
Catacol,
Hypoxanthine 9-|A-D-ribofuranoside,
NSC20262,
9-.beta.-D-Ribofuranosylhypoxanthine,
3h-inosine,
D-Inosine,
2ada,
2fqw,
.beta.-D-Ribofuranoside, hypoxanthine-9,
NCGC00095787-01,
Hypoxanthine, 9-.beta.-D-ribofuranosyl-,
Inosine,(S),
Inotin (TN),
Inosine (JAN/INN),
PubChem14189,
1a4m,
Inosine (8CI,9CI),
AC1L1LMO,
Opera_ID_1628,
bmse000098,
bmse000888,
bmse000978,
cid_6021,
CHEMBL1556,
SCHEMBL15804,
KBioGR_002560,
KBioSS_002569,
KSC269S6L,
ARONIS24558,
AC1Q77T9,
GTPL4554,
9-b-D-Ribofuranosylhypoxanthine,
Inosine, >=99% (HPLC),
DTXSID2045993,
9beta-D-Ribofuranosylhypoxanthine,
BDBM22104,
CTK1G9965,
KBio2_002560,
KBio2_005128,
KBio2_007696,
KBio3_003038,
9-b-D-ribofuranosyl-Hypoxanthine,
cMAP_000084,
HMS2235I17,
Hypoxanthine-9-delta-ribofuranoside,
9-beta-D-ribofuranosyl-Hypoxanthine,
HY-N0092,
ZINC8855117,
9beta-delta-Ribofuranosylhypoxanthine,
Tox21_111522,
AN-889,
ANW-33000,
BDBM50366815,
beta-D-Ribofuranoside hypoxanthine-9,
hypoxanthine-9 beta-D-Ribofuranoside,
s2442,
9-beta-delta-Ribofuranosylhypoxanthine,
AKOS015969695,
AKOS015995607,
AKOS024462561,
Tox21_111522_1,
9-beta-D-ribofuranosyl-9H-purin-6-ol,
9-beta-delta-ribofuranosyl-Hypoxanthine,
AM83935,
CS-5845,
DB04335,
MCULE-3095132846,
RTR-037177,
beta-delta-Ribofuranoside hypoxanthine-9,
Hypoxanthine 9-beta-delta-ribofuranoside,
hypoxanthine-9 beta-delta-Ribofuranoside,
Hypoxanthine-9-beta-delta-ribofuranoside,
SMP1_000165,
NCGC00096119-02,
NCGC00096119-03,
AS-11754,
CJ-13587,
LS-84000,
9-(beta-D-ribofuranosyl)-9H-purin-6-ol,
AB0066076,
AB1000320,
DB-029916,
TR-037177,
FT-0627217,
I0037,
A-8687,
C00294,
D00054,
J10406,
1,9-dihydro-9-b-D-ribofuranosyl-6H-Purin-6-one,
SR-01000721862-2,
SR-01000721862-3,
AC89F8E4-FD89-45EE-8B41-94DFC07AB42F,
BRD-K79612754-001-21-7,
1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one,
6H-Purin-6-one, 1,9-dihydro-9-beta-D-ribofuranosyl-,
9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one (Inosine),
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-3,4-diol,
9-(3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1,9-DIHYDRO-PURIN-6-ONE,
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one,
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one,
9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one,
InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s,
riboxine,
inosin-,
Inosine-,
Hypoxanthine arabinoside,
INDOLE-3-CARBOXALDEHYDE,
C10H12N4O5,
INO-1001,
CID6021,
Inosine 99% for biochemistry 5gm,
C10-H12-N4-O5,
Inosine, 99% - 100G 100g,
B3677,
Inosine (<lt/> 100 microg/ml) in methanol,
D007288,
|
| Complexity | 405 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 268.081g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 19 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 4 |
| Isotope Atom Count | 0 |
| Molecular Weight | 268.229g/mol |
| Monoisotopic Mass | 268.081g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 129A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.3 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

